Abstract: Compounds of the formula: ##STR1## are disclosed wherein X is NH, O or S and the tautomers thereof when X is nitrogen, and Y is hydrogen, lower alkyl, hydroxy, lower alkoxy, chloro, bromo or aryl. These compounds are useful in the management of allergic manifestations such as bronchial asthma.

Abstract: The specific embodiments provide a razor blade comprising at least one cutting edge, and an adherent fluorocarbon polymer coating on the cutting edge. The coating has microscopic raised portions. There is also provided a method of treating a razor blade comprising depositing on the cutting edge of the blade a composition comprising a first fluorocarbon polymer and a second fluorocarbon polymer having a molecular weight greater than the first polymer. The deposited composition is heated at a temperature sufficient to cause the first polymer to melt and flow and insufficient to cause the second polymer to melt and flow. Alternatively, the molecular weights of the two polymers are chosen to be sufficiently different such that when the two polymers melt during a heating step the viscosity of the high molecular weight second polymer is sufficiently high to avoid or at least minimize flow.

Abstract: The present invention relates to novel thiazolidinone acetic acid derivatives and their preparation. These derivatives show diuretic properties when used as pharmaceuticals.

Abstract: This invention relates to novel benzo- and tetrahydrobenzo-[f,g and h]pyrido[2,1-b]quinazolin-ones and their methods of preparation. These compounds have utility as antiallergy agents.

Abstract: The present invention relates to 7-substituted triol derivatives of the novel antibiotic substance, acid S, produced by the organism Polyangium cellulosum var. fulvum (ATCC No. 25532) and to processes for their preparation. The 7-substituted triol derivatives of acid S of this invention are useful as antifungal agents.

Abstract: Novel 3-formylchromone derivatives are disclosed, substituted on the 5,6,7, or 8 positions by one or more of the following substituents: halogen, hydroxy, lower alkyl, lower alkoxy, lower acyl, lower acyloxy, or methylenedioxy. The corresponding 3-acetal or 3-hydrazone derivatives of the carboxaldehyde group are also disclosed. These compoounds, and pharmaceutical compositions containing these compounds are useful for the treatment of allergic conditions and for the treatment of hyperacidity.

Abstract: This invention relates to 4r-amino-1t-phenyl-1c-ethoxycarbonyl-cyclohexenes-(2) of formula I: ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and are hydrogen or alkyl having 1 to 4 carbon atoms, or one of the two groups is allyl, phenalkyl having 7 to 9 carbon atoms or .alpha.-methyl-.beta.-hydroxyethyl; or R.sub.1 and R.sub.2 together form a morpholino group, piperazino group substituted at the 4- position by methyl, benzyl, phenyl, 3-chlorophenyl, 4-chlorophenyl, 2-phenethyl or benzoyl, or a piperidino group substituted at the 4- position by hydroxyl, phenyl, 2-methoxyphenyl, 4-methoxyphenyl, methyl or benzyl and medically acceptable addition compounds derived from inorganic and organic acids or lower alkyl halides. The compounds of the present invention are prepared by separation of 4-amino-1-phenyl-1-ethoxycarbonyl-cyclohexenes-(2), described in U.S. Patent Application Ser. No. 226,509, filed Feb. 15, 1972, into the two possible geometrical isomers.

Abstract: There are disclosed 7-substituted-9-oxoxanthene-2-carboxaldehydes of the formula: ##STR1## in which R is lower alkoxy or hydroxy. These compounds are indicated in the management of allergic manifestations such as, for example, bronchial asthma or hay fever.

Abstract: Substituted 3-(2-pyridinyl)-4-(1H)-quinolinone N-oxides having the formula I: ##STR1## wherein R.sub.1 is hydrogen, halogen, lower alkyl, hydroxy or alkoxy; R.sub.2 is hydrogen or lower alkyl; R.sub.3 is hydrogen or --CH.sub.2 OH; the dotted line indicates the possible presence of a double bond at the 2,3-position of the quinoline ring; the pharmaceutically acceptable acid addition salts thereof; and a process for the preparation thereof, are described. The compounds of the invention are useful for the treatment of hyperacidity and for the prevention of allergic and asthmatic reactions.

Abstract: Processes for the production of the compounds of the formula: ##STR1## are disclosed. In the above formula, R.sub.1 is aryl which may be substituted or unsubstituted; R.sub.2 is hydrogen, alkyl, aryl, aralkyl, alkoxy, halogen, cyano, nitro, trifluoromethyl and the like.These compounds are prepared by the following reaction schemes: ##STR2## These compounds are useful as anti-inflammatory agents.

Abstract: Direct agglutination reagent for pregnancy testing which comprises the use of suspensions of polystyrene latex particles sensitized with a globulin fraction of anti-serum to human chorionic gonadotropin (HCG). When mixed with urine or blood serum samples containing HCG, this reagent agglutinates indicating a positive test for pregnancy.

Abstract: The present invention relates to a process for 3r-N-Monomethylamino-4 cis-phenyl-4 trans-ethoxycarbonyl-cyclohexene and its N-substitution products which are generally useful as analgesics.

Abstract: A soluble lyophilized collagen preparation is disclosed which is capable of reproducible aggregating platelets.

Abstract: Disclosed are a stable, non-protein, buffered control material for monitoring the reliability of blood gas instruments in the acid, normal, and alkaline ranges.

Abstract: The present invention relates to novel thiazolidinone acetic acid derivatives and their preparation. These derivatives show diuretic properties when used as pharmaceuticals.

Abstract: Compounds of the formula: ##STR1## are disclosed. In this structural formula X is ##STR2## and Y is hydrogen, lower alkyl, hydroxy, lower alkoxy, chloro, bromo or aryl. Included within the scope of this invention are tautomers of the above compound. These compounds and their tautomers are indicated in the management of allergic manifestations such as bronchial asthma.

Abstract: Water-wettable anhydrous products, such as the powders and creams used in cosmetic and drug products, are admixed with 20% to 60% by weight, based on the weight of the total formulation, of a powdered polyethylene or powdered polypropylene polymer, to improve wettability characteristics. Denture adhesive powders prepared from an anionic/cationic adhesive combination, together with the powdered polyethylene or polypropylene polymer display particularly improved properties. The polyethylene or polypropylene polymer may also be admixed with other anhydrous products including dentifrices, vaginal powder sprays, and the like. Low molecular weight polyethylene powder, with an average molecular weight of from 1,000 to 3,500, is suitable for use in products of the invention. For the polypropylene, a molecular weight of from 120,000 to 350,000 is specified. The powdered polymers have a particle size of less than 422 microns.

Abstract: The present invention describes octahydro and decahydro derivatives of the novel antibiotic substance, acid S, produced by the organism Polyangium cellulosum var. fulvum (ATCC No. 25532) and to processes for their preparation. The octahydro and dechydro derivatives of acid S of this invention are useful as antifungal and antibacterial agents.

Abstract: This invention relates to a method for installing a friction lock retaining pin into a tooth through the use of ultrasonic vibrations and an apparatus by which conventional ultrasonic dental scalers may be adapted for use in this method.

Abstract: Reinforced silicone elastomers, having improved tensile strength and particularly tear strength, include at least copolymers of aryl siloxanes and alkyl siloxanes, in a ratio of aryl to alkyl substituents providing 6 to 16 mole percent phenyl chosen to provide a refractive index matched to the index of refraction of a silica filler, form optically clear material useful for soft contact lenses. Preferably two copolymers are used and each has methyl groups with 6 to 16 mole percent phenyl groups. One of the two copolymers contains terminal vinyl groups and the other copolymer contains terminal (R).sub.2 HSi--O-- groups. Platinum materials are used to catalyze the vulcanization of the copolymer mix. These elastomers are useful for a variety of optical products, e.g., contact lenses, intraocular implants and the like.